TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Prif Awdur: | Afroza, Halima |
---|---|
Awduron Eraill: | Talukder, Mesbah |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2024
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/22075 |
Eitemau Tebyg
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
gan: Islam, Nahidul
Cyhoeddwyd: (2023) -
Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
gan: Tamanna, Shams Tahsin
Cyhoeddwyd: (2020) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
gan: Islam, S.M. Zahidul
Cyhoeddwyd: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
gan: Khandker, Tahia Anjum
Cyhoeddwyd: (2024) -
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
gan: Akter, Anika
Cyhoeddwyd: (2022)